The purpose of the Tissue and Pathology and Core, which will be located within the Departments of Pathology at Brigham and Women's Hospital, Massachusetts General Hospital, and the Beth Israel Deaconess Medical Center, is to provide to all SPORE investigators with: 1. Research pathology services including expert diagnosticians to confirm diagnoses and ensure consistency in reporting of all human tissue samples utilize by researchers and provide technical and laboratory facilities including a comprehensive range of resource such as immunohistochemistry and in situ hybridization for both frozen and paraffin-embedded material, in situ hybridization, fluorescence based flow cytometry and microscopy for quantitative and qualitative analysis of cell surface and intracellular molecules, computer assisted image analysis, digital imaging, and laser capture microdissection. These facilities will provide SPORE investigators with essential services for diagnosis confirmation and the evaluation of new markers, probes and antibodies. The Core will contain the appropriate equipment, reagents, and technical expertise to provide the services using the facilities described above. Personnel in the Pathology Core will be available to advise investigators on technical aspects of the Core facilities in addition to help with interpretation of results. 2. A Tissue/Blood Repository/Virtual Tissue Bank, including collection, and storage of fresh tissue samples and collection, processing and storage of blood and blood components from patients with malignant melanoma, congenital nevi, cutaneous T-cell lymphoma, cutaneous squamous cell carcinoma, and vascular tumors enrolled in the SPORE-related projects. The Virtual Tissue Bank will link the extensive resources of the Dana Farber/Harvard Cancer Center-associated hospitals. The investigators will therefore be provided with ready access to a wide range of related clinical material with associated clinical information. In the context of all access to a wide range of related clinical material with associated clinical information. In the context of all human tissues, there will be close collaboration between the Tissue and Pathology Core and the Clinical Data Management Core which will assume responsibility for providing and maintaining the clinical databases for Management Core which will assume responsibility for providing and maintaining the clinical databases.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA093683-01
Application #
6543410
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2001-09-30
Project End
2006-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
de Masson, Adele; O'Malley, John T; Elco, Christopher P et al. (2018) High-throughput sequencing of the T cell receptor ? gene identifies aggressive early-stage mycosis fungoides. Sci Transl Med 10:
Sung, Hyeran; Kanchi, Krishna L; Wang, Xue et al. (2016) Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activation. Oncotarget 7:23885-96
Kirsch, Ilan R; Watanabe, Rei; O'Malley, John T et al. (2015) TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL. Sci Transl Med 7:308ra158
Lee, Jonathan J; Granter, Scott R; Laga, Alvaro C et al. (2015) 5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies. Mod Pathol 28:218-29
Ma, Jie; Frank, Markus H (2015) Isolation of Circulating Melanoma Cells. Methods Mol Biol :
Jain, Salvia; Stroopinsky, Dina; Yin, Li et al. (2015) Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma. Blood 126:354-62
Watanabe, Rei; Gehad, Ahmed; Yang, Chao et al. (2015) Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. Sci Transl Med 7:279ra39
Lee, Jonathan J; Cook, Martin; Mihm, Martin C et al. (2015) Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma. Oncotarget 6:37995-8004
Bhela, Siddheshvar; Kempsell, Christine; Manohar, Monali et al. (2015) Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6. J Immunol 194:2180-9
Lee, Jonathan J; Sholl, Lynette M; Lindeman, Neal I et al. (2015) Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas. Clin Epigenetics 7:59

Showing the most recent 10 out of 132 publications